Daniel P Petrylak

Publication Activity (10 Years)

Years Active: 2021-2024
Publications (10 Years): 26

Top Topics

Locally Advanced

Advanced Non Small Cell Lung Cancer

Top Venues

Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Clinical cancer research : an official journal of the American Association for Cancer Research

Future oncology (London, England)

Cancer discovery

This page only lists publications with an associated author ORCID identifier.

Publications

Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Yohann Loriot, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Petros D Grivas, Aude Flechon, Rohit K Jain, Umang Swami, Manojkumar Bupathi, Philippe Barthélémy, Philippe Beuzeboc, Phillip L Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Julia Tonelli, Mitch Sierecki, Marianna Zavodovskaya, Emon Elboudwarej, Lauri Diehl, Juliane M Jürgensmeier, Scott T Tagawa
Sacituzumab Govitecan Demonstrates Efficacy across Tumor Trop-2 Expression Levels in Patients with Advanced Urothelial Cancer. Clinical cancer research : an official journal of the American Association for Cancer Research 30 (15) (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Daniel P Petrylak, Scott T Tagawa, Rohit K Jain, Manojkumar Bupathi, Arjun V Balar, Arash Rezazadeh Kalebasty, Saby George, Phillip Palmbos, Luke Nordquist, Nancy B Davis, Chethan Ramamurthy, Cora N Sternberg, Yohann Loriot, Archana M Agarwal, Chandler Park, Julia Tonelli, Morganna Vance, Huafeng Zhou, Petros D Grivas
TROPHY-U-01 Cohort 2: A Phase II Study of Sacituzumab Govitecan in Cisplatin-Ineligible Patients With Metastatic Urothelial Cancer Progressing After Previous Checkpoint Inhibitor Therapy. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2024)
Matthew I Milowsky, Peter H O'Donnell, Christopher J Hoimes, Daniel P Petrylak, Thomas W Flaig, Helen H Moon, Terence W Friedlander, Nataliya Mar, Rana R McKay, Sandy Srinivas, Gwenaëlle Gravis, Chethan Ramamurthy, Manojkumar Bupathi, Sergio Bracarda, Phoebe Wright, Zsolt Hepp, Anne-Sophie Carret, Yao Yu, Ryan Dillon, Ritesh Kataria, Jennifer L Beaumont, Intan Purnajo, Jonathan E Rosenberg
Patient-Reported Outcomes in Patients With Advanced Urothelial Cancer Who Are Ineligible for Cisplatin and Treated With First-Line Enfortumab Vedotin Alone or With Pembrolizumab. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Petros D Grivas, Damien Pouessel, Chandler H Park, Philippe Barthelemy, Manojkumar Bupathi, Daniel P Petrylak, Archana M Agarwal, Sumati V Gupta, Aude Fléchon, Chethan Ramamurthy, Nancy B Davis, Alejandro Recio-Boiles, Cora N Sternberg, Astha Bhatia, Cabilia Pichardo, Mitch Sierecki, Julia Tonelli, Huafeng Zhou, Scott T Tagawa, Yohann Loriot
Sacituzumab Govitecan in Combination With Pembrolizumab for Patients With Metastatic Urothelial Cancer That Progressed After Platinum-Based Chemotherapy: TROPHY-U-01 Cohort 3. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 42 (12) (2024)
Peter H O'Donnell, Matthew I Milowsky, Daniel P Petrylak, Christopher J Hoimes, Thomas W Flaig, Nataliya Mar, Helen H Moon, Terence W Friedlander, Rana R McKay, Mehmet Asim Bilen, Sandy Srinivas, Earle F Burgess, Chethan Ramamurthy, Saby George, Daniel M Geynisman, Sergio Bracarda, Delphine Borchiellini, Lionnel Geoffrois, Jose Pablo Maroto Rey, Christiano Ferrario, Anne-Sophie Carret, Yao Yu, Maria Guseva, Blanca Homet Moreno, Jonathan E Rosenberg
Enfortumab Vedotin With or Without Pembrolizumab in Cisplatin-Ineligible Patients With Previously Untreated Locally Advanced or Metastatic Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Sandra Santasusagna, Shijia Zhu, Vijayakumar Jawalagatti, Marc Carceles-Cordon, Adam Ertel, Saioa Garcia-Longarte, Won-Min Song, Naoto Fujiwara, Peiyao Li, Isabel Mendizabal, Daniel P Petrylak, William Kevin Kelly, E Premkumar Reddy, Liguo Wang, Matthew J Schiewer, Amaia Lujambio, Robert Jeffrey Karnes, Beatrice Knudsen, Carlos Cordon-Cardo, Haidong Dong, Zhenlin Huang, Arkaitz Carracedo, Yujin Hoshida, Veronica Rodriguez-Bravo, Josep Domingo-Domenech
Master transcription factor reprograming unleashes selective translation promoting castration resistance and immune evasion in lethal prostate cancer. Cancer discovery (2023)
Susan Halabi, Qian Yang, Akash Roy, Bin Luo, John C Araujo, Christopher Logothetis, Cora N Sternberg, Andrew J Armstrong, Michael A Carducci, Kim N Chi, Johann S de Bono, Daniel P Petrylak, Karim Fizazi, Celestia S Higano, Michael J Morris, Dana E Rathkopf, Fred Saad, Charles J Ryan, Eric J Small, William Kevin Kelly
External Validation of a Prognostic Model of Overall Survival in Men With Chemotherapy-Naïve Metastatic Castration-Resistant Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2023)
Emmanuel S Antonarakis, Sumit K Subudhi, Christopher M Pieczonka, Lawrence Ivan Karsh, David I Quinn, Jason M Hafron, Helen M Wilfehrt, Matthew Harmon, Nadeem A Sheikh, Neal D Shore, Daniel P Petrylak
Combination Treatment with Sipuleucel-T and Abiraterone Acetate or Enzalutamide for Metastatic Castration-Resistant Prostate Cancer: STAMP and STRIDE Trials. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Daniel P Petrylak, Bernhard J Eigl, Saby George, Elisabeth I Heath, Sebastien J Hotte, David D Chism, Lisle M Nabell, Joel Picus, Susanna Y Cheng, Leonard J Appleman, Guru P Sonpavde, Alicia K Morgans, Pourya Pourhosseini, Ruishan Wu, Laura Standley, Ruslan Croitoru, Evan Y Yu
Phase 1 Dose-Escalation Study of the Safety and Pharmacokinetics of AGS15E Monotherapy in Patients With Metastatic Urothelial Carcinoma. Clinical cancer research : an official journal of the American Association for Cancer Research (2023)
Christopher J Hoimes, Thomas W Flaig, Matthew I Milowsky, Terence W Friedlander, Mehmet Asim Bilen, Shilpa Gupta, Sandy Srinivas, Jaime R Merchan, Rana R McKay, Daniel P Petrylak, Carolyn Sasse, Blanca Homet Moreno, Yao Yu, Anne-Sophie Carret, Jonathan E Rosenberg
Enfortumab Vedotin Plus Pembrolizumab in Previously Untreated Advanced Urothelial Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Andrew J Armstrong, Arun A Azad, Taro Iguchi, Russell Z Szmulewitz, Daniel P Petrylak, Jeffrey Holzbeierlein, Arnauld Villers, Antonio Alcaraz, Boris Alekseev, Neal D Shore, Francisco Gomez-Veiga, Brad Rosbrook, Fabian Zohren, Shunsuke Yamada, Gabriel P Haas, Arnulf Stenzl
Improved Survival With Enzalutamide in Patients With Metastatic Hormone-Sensitive Prostate Cancer. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 40 (15) (2022)
Cora N Sternberg, Daniel P Petrylak, Joaquim Bellmunt, Hiroyuki Nishiyama, Andrea Necchi, Howard Gurney, Jae Lyun Lee, Michiel S Van Der Heijden, Eli Rosenbaum, Nicolas Penel, See-Tong Pang, Jian-Ri Li, Xavier García Del Muro Solans, Florence Joly Lobbedez, Zsuzsanna Pápai, Weichao Bao, Peter Ellinghaus, Chengxing Lu, Mitchell Sierecki, Sabine Coppieters, Keiko Nakajima, Tatiane Cristine Ishida, David I Quinn
FORT-1: Phase II/III Study of Rogaratinib Versus Chemotherapy in Patients With Locally Advanced or Metastatic Urothelial Carcinoma Selected Based on FGFR1 / 3 mRNA Expression. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Joseph W Kim, Rana R McKay, Marc R Radke, Shilin Zhao, Mary-Ellen Taplin, Nancy B Davis, Paul Monk, Leonard J Appleman, Primo N Lara, Ulka N Vaishampayan, Jingsong Zhang, Asit K Paul, Glenn Bubley, Eliezer Van Allen, Serhan Ünlü, Ying Huang, Massimo Loda, Geoffrey I Shapiro, Peter M Glazer, Patricia M LoRusso, Susan Percy Ivy, Yu Shyr, Elizabeth M Swisher, Daniel P Petrylak
Randomized Trial of Olaparib With or Without Cediranib for Metastatic Castration-Resistant Prostate Cancer: The Results From National Cancer Institute 9984. Journal of clinical oncology : official journal of the American Society of Clinical Oncology (2022)
Daniel P Petrylak, Raffaele Ratta, Rustem Airatovich Gafanov, Gaetano Facchini, Josep Maria Piulats, Gero Kramer, Thomas W Flaig, Sreenivasa R Chandana, Ben Li, Joseph Burgents, Karim Fizazi
KEYNOTE-921: Phase III study of pembrolizumab plus docetaxel for metastatic castration-resistant prostate cancer. Future oncology (London, England) 17 (25) (2021)
Scott T Tagawa, Arjun V Balar, Daniel P Petrylak, Arash Rezazadeh Kalebasty, Yohann Loriot, Aude Fléchon, Rohit K Jain, Archana M Agarwal, Manojkumar Bupathi, Philippe Barthelemy, Philippe Beuzeboc, Phillip Palmbos, Christos E Kyriakopoulos, Damien Pouessel, Cora N Sternberg, Quan Hong, Trishna Goswami, Loretta M Itri, Petros D Grivas
TROPHY-U-01: A Phase II Open-Label Study of Sacituzumab Govitecan in Patients With Metastatic Urothelial Carcinoma Progressing After Platinum-Based Chemotherapy and Checkpoint Inhibitors. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (22) (2021)
Thomas Powles, Daniel P Petrylak, Jonathan E Rosenberg
Beyond Chemotherapy and Checkpoint Inhibitors: Weighing the Risks and Benefits of the Novel Therapies for Metastatic Urothelial Carcinoma. Journal of clinical oncology : official journal of the American Society of Clinical Oncology 39 (30) (2021)